Virtual meeting
Via Zoom
Description
As part of the twice-monthly MA OBAT ECHO® series, Joji Suzuki, MD, will describe the current evidence base, proposed mechanisms, and safety considerations for psychedelic substances in the treatment of mental health and substance use disorders.. He will also apply a health-promotion framework to counsel patients about psychedelic use, including screening for risk, discussing potential benefits and harms, and addressing legal and ethical considerations in clinical practice. The didactic session will be followed by an extended discussion and question and answer period. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
Boston Medical Center's (BMC) 12-part Massachusetts Office Based Addiction Treatment ECHO® (MA OBAT ECHO®) offers training and support in addiction treatment, with a focus on comprehensive care for patients with substance use disorders (SUDs). The free, case-based tele-mentoring program is designed to increase the capacity of primary care teams to integrate addiction treatment using a multidisciplinary care model.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Joji Suzuki, MD
Dr. Suzuki is the Director of the Division of Addiction Psychiatry and Director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital, and an Assistant Professor of Psychiatry at Harvard Medical School. His areas of clinical and research interests are the assessment and management of substance use disorders and related conditions in general medical settings, motivational interviewing, office-based opioid treatment, implementation of collaborative models of care, and medical education. He is the site director for the Partners Addiction Psychiatry Fellowship, and is involved with teaching medical students, residents, and allied health professionals. He has authored over 30 peer-reviewed manuscripts and book chapters related to addiction psychiatry.
Objectives
At the conclusion of this activity, participants will have the knowledge to:
-
Describe the current evidence base, proposed mechanisms, and safety considerations for psychedelic substances in the treatment of mental health and substance use disorders.
-
Apply a health-promotion framework to counsel patients about psychedelic use, including screening for risk, discussing potential benefits and harms, and addressing legal and ethical considerations in clinical practice.
Sponsored by
Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
Accreditation information
Please read the Accreditation Information section of the training registration page for more information and to learn about the requirements for receiving credit or a certificate of completion.
Audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
